Coffee consumption linked with reduced risk of diabetes

February 17, 2014
Coffee consumption linked with reduced risk of diabetes

(HealthDay)—Higher consumption of coffee is associated with lower risk of type 2 diabetes, according to research published in the February issue of Diabetes Care.

Ming Ding, of the Harvard School of Public Health in Boston, and colleagues conducted a systematic review of the literature and performed a meta-analysis of 28 prospective cohort or nested case-control studies. The authors sought to assess the effect of consumption on risk of type 2 .

The researchers found that, compared with no coffee or rare consumption of coffee, the relative risk (RR) for type 2 diabetes was 0.92 (95 percent confidence interval [CI], 0.90 to 0.94) for one cup per day; 0.85 (95 percent CI, 0.82 to 0.88) for two cups per day; 0.79 (95 percent CI, 0.75 to 0.83) for three cups per day; 0.75 (95 percent CI, 0.71 to 0.80) for four cups per day; 0.71 (95 percent CI, 0.65 to 0.76) for five cups per day; and 0.67 (95 percent CI, 0.61 to 0.74) for six cups per day. No significant difference was found between the reduced risk of diabetes associated with a one cup per day increase for caffeinated coffee (RR, 0.91; 95 percent CI, 0.89 to 0.94) versus decaffeinated coffee (RR, 0.94; 95 percent CI, 0.91 to 0.98) (P for difference = 0.17).

"Coffee consumption was inversely associated with the risk of type 2 diabetes in a dose-response manner," the authors write. "Both caffeinated and decaffeinated coffee was associated with reduced ."

Explore further: Melanoma risk up in IBD independent of biologic therapy

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Melanoma risk up in IBD independent of biologic therapy

January 31, 2014
(HealthDay)—Inflammatory bowel disease (IBD) is associated with an increased risk of melanoma, independent of the use of biologic therapy, according to research published in the February issue of Clinical Gastroenterology ...

Metformin use doesn't cut incidence of bladder cancer

February 11, 2014
(HealthDay)—For patients with type 2 diabetes, metformin use is not associated with a significantly reduced risk of bladder cancer, according to a study published online Feb. 4 in Diabetes Care.

High overall CRC diagnostic accuracy for home stool test

February 4, 2014
(HealthDay)—Fecal immunochemical tests (FITs) have moderate sensitivity, high specificity, and high overall diagnostic accuracy for detecting colorectal cancer (CRC), according to research published in the Feb. 4 issue ...

Osteoporosis / Osteopenia prevalent in chronic pancreatitis

January 31, 2014
(HealthDay)—Sixty-five percent of patients with chronic pancreatitis have osteoporosis or osteopenia, according to a meta-analysis published in the February issue of Clinical Gastroenterology and Hepatology.

Clopidogrel after MI less effective in diabetes patients

September 5, 2012
(HealthDay)—Clopidogrel therapy following a heart attack does less to reduce the risk of death in patients with diabetes than in those without diabetes, according to a study published in the Sept. 5 issue of the Journal ...

Caffeinated coffee may reduce the risk of oral cancers

December 10, 2012
A new American Cancer Society study finds a strong inverse association between caffeinated coffee intake and oral/pharyngeal cancer mortality. The authors say people who drank more than four cups of caffeinated coffee per ...

Recommended for you

Smart mat detects early warning signs of foot ulcers

August 16, 2017
While completing his residency in anesthesiology at Massachusetts General Hospital in the mid-2000s, Jon Bloom saw his fair share of foot amputations among patients with diabetes. The culprit: infected foot ulcers.

The best place to treat type 1 diabetes might be just under your skin

August 14, 2017
A group of U of T researchers have demonstrated that the space under our skin might be an optimal location to treat type 1 diabetes (T1D).

New measure of insulin-making cells could gauge diabetes progression, treatment

August 10, 2017
Researchers at the University of Wisconsin-Madison have developed a new measurement for the volume and activity of beta cells, the source of the sugar-regulating hormone insulin.

Pioneering immunotherapy shows promise in type 1 diabetes

August 9, 2017
It may be possible to 'retrain' the immune system to slow the progression of type 1 diabetes, according to results of a clinical trial published today in the journal Science Translational Medicine.

Online team-based game helps patients with diabetes lower blood glucose

August 8, 2017
Researchers from Brigham and Women's Hospital and the Veterans Affairs Boston Healthcare System have found that an online, team-based game designed to teach patients about diabetes self-management had a sustained and meaningful ...

Oxidative stress biomarkers don't always signal diabetes risk

August 7, 2017
High levels of compounds found in the body that are commonly associated with oxidative damage may actually be a good sign for some people, according to a recent review of multiple human studies led by an epidemiologist at ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.